Annual report pursuant to Section 13 and 15(d)

STATEMENTS OF OPERATIONS

v3.24.0.1
STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Operating expenses:    
Research and development $ 1,728,078 $ 8,069,628
General and administrative expenses 3,718,841 4,245,681
Total operating expenses 5,446,919 12,315,309
Loss from operations (5,446,919) (12,315,309)
Other income:    
Interest income 150,904 67,475
Total other income 150,904 67,475
Loss before income taxes (5,296,015) (12,247,834)
Net loss $ (5,296,015) $ (12,247,834)
Basic net loss per share (in dollars per share) $ (0.28) $ (1.11)
Diluted net loss per share (in dollars per share) $ (0.28) $ (1.11)
Weighted average number of shares outstanding - basic (in shares) 18,776,790 11,070,116
Weighted average number of shares outstanding - diluted (in shares) 18,776,790 11,070,116